Wolverine Trading
CAPR icon

Wolverine Trading’s Capricor Therapeutics CAPR Stock Holding History

Wolverine Trading’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$526K Buy
70,924
+23,998
+51% +$177K ﹤0.01% 3659
2025
Q2 		$523K Buy
+46,926
New +$496K ﹤0.01% 2901

Other funds holding CAPR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $606M AUM 63.41% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Wolverine Trading's CAPR Position: Q3 2025 in Review

Wolverine Trading increased its Capricor Therapeutics (CAPR) stake by 51% in Q3 2025, buying an estimated $177K and bringing the position to 70,924 shares worth $526K. The position accounts for ﹤0.01% of the portfolio, ranked #3659.

Wolverine Trading first reported a position in CAPR in Q2 2025 and has held it in 2 quarters since. 115 funds tracked by Wall St. Rank hold CAPR as of Q3 2025.

  • Wolverine Trading held 70,924 shares of Capricor Therapeutics worth $526K as of Q3 2025.
  • Wolverine Trading bought 23,998 Capricor Therapeutics shares in Q3 2025, an estimated $177K.
  • Capricor Therapeutics made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #3659 holding.
  • Wolverine Trading first reported a position in Capricor Therapeutics in Q2 2025 and has held it in 2 quarters since.
  • 115 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.